In addition, in most studies, a third of the patients who were randomized to receive auto-HCT never underwent transplant due to progressive disease or patient choice. There were also significant ...
An exploratory analysis of OS in the MRD-positive patients showed a 3-year OS of 100% with HCT and rituximab in 17 patients who converted to uMRD after transplantation. That contrasted with 63.6% ...
A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.
He has a major research interest in the application of HCT for patients with acute leukemia ... of two multi-center NIH-supported clinical transplantation trials in leukemia.